Envista (NYSE:NVST) Stock Price Up 6.4% – Should You Buy?

Envista Holdings Corporation (NYSE:NVST) shares were up 6.4% on Wednesday . The stock traded as high as $28.80 and last traded at $28.6790. Approximately 1,429,926 shares traded hands during mid-day trading, a decline of 51% from the average session volume of 2,890,498 shares. The stock had previously closed at $26.96.

Analyst Ratings Changes

Several equities research analysts have commented on NVST shares. Evercore reaffirmed an “outperform” rating and set a $33.00 price objective on shares of Envista in a report on Thursday, May 7th. Barclays reduced their target price on shares of Envista from $34.00 to $32.00 and set an “overweight” rating for the company in a research note on Thursday, June 11th. BMO Capital Markets began coverage on shares of Envista in a research report on Wednesday, July 8th. They issued a “market perform” rating and a $27.00 price target on the stock. Piper Sandler boosted their price target on shares of Envista from $25.00 to $26.00 and gave the company a “neutral” rating in a research report on Wednesday. Finally, Morgan Stanley upped their price target on shares of Envista from $19.00 to $21.00 and gave the company an “equal weight” rating in a research note on Friday, April 24th. Six analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $28.62.

Envista Stock Down 2.0%

The stock has a fifty day simple moving average of $25.52 and a two-hundred day simple moving average of $25.88. The firm has a market cap of $4.52 billion, a PE ratio of 67.81, a price-to-earnings-growth ratio of 1.61 and a beta of 0.86. The company has a current ratio of 2.44, a quick ratio of 2.06 and a debt-to-equity ratio of 0.47.

Envista (NYSE:NVST) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.31 by $0.05. The firm had revenue of $705.50 million for the quarter, compared to the consensus estimate of $680.03 million. Envista had a net margin of 2.41% and a return on equity of 7.11%. The company’s revenue for the quarter was up 14.4% on a year-over-year basis. During the same period in the prior year, the firm posted $0.24 earnings per share. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. As a group, sell-side analysts expect that Envista Holdings Corporation will post 1.42 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of NVST. Parallel Advisors LLC grew its holdings in Envista by 13.1% in the 4th quarter. Parallel Advisors LLC now owns 3,175 shares of the company’s stock worth $69,000 after acquiring an additional 367 shares during the last quarter. Bank of Montreal Can raised its stake in shares of Envista by 1.4% during the fourth quarter. Bank of Montreal Can now owns 26,178 shares of the company’s stock valued at $568,000 after acquiring an additional 372 shares during the last quarter. Sepio Capital LP boosted its holdings in shares of Envista by 1.2% during the fourth quarter. Sepio Capital LP now owns 31,632 shares of the company’s stock worth $687,000 after purchasing an additional 374 shares during the period. Deutsche Bank AG grew its stake in shares of Envista by 2.9% in the fourth quarter. Deutsche Bank AG now owns 17,412 shares of the company’s stock worth $378,000 after purchasing an additional 484 shares during the last quarter. Finally, State of Michigan Retirement System grew its stake in shares of Envista by 1.5% in the first quarter. State of Michigan Retirement System now owns 39,463 shares of the company’s stock worth $1,001,000 after purchasing an additional 600 shares during the last quarter.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.